RGEN
Repligen Surpasses $209 Million in Revenue, Accelerates Growth with BioLife Acquisition
Repligen, a leading provider of bioprocessing technologies and services, has announced a record-breaking quarter with $209 million in revenue, surpassing its prior peak in 2022. The company's diversified portfolio, driven by Proteins and Chromatography, played a significant role in this achievement. According to Olivier Loeillot, President and Chief